<DOC>
	<DOCNO>NCT02054429</DOCNO>
	<brief_summary>The purpose study determine safety efficacy lower glucose ( blood sugar ) , addition endovascular therapy , acute ischemic stroke . The study determine lower glucose ( blood sugar ) addition endovascular therapy improve 90-day functional neurological outcome comparison standard glycemic care patient acute ischemic stroke . The study involve treatment 100 ( 50 intensive insulin therapy 50 standard glycemic control ) non-diabetic patient present within 8 hour acute ischemic stroke undergone endovascular therapy .</brief_summary>
	<brief_title>Intensive Insulin Therapy With Tight Glycemic Control Improve Outcomes After Endovascular Therapy Acute Ischemic Stroke</brief_title>
	<detailed_description>This prospective open label study 100 subject randomize either insulin aspart ( study drug ) infusion ( intensive insulin therapy [ IIT arm ] ) 48hrs control arm . All patient attend emergency department ( ED ) Kaleida health within 24 hrs symptom onset suggestive anterior circulation ischemic stroke screen . If meet inclusion criterion exclusion criterion , inform consent obtain blind stratified block randomization process initiate . In addition receive endovascular standard medical therapy AIS , subject randomize intensive insulin treatment arm ( IIT arm ) control arm . In IIT arm subject receive insulin aspart infusion minimal rate 2 units/hr maintain blood glucose 90-120mg/dl 48 hr . Glucose control control discretion treat provider . Subjects follow study procedure do different time point : A ) assessment neurological outcome : modify Rankin scale ( mRS ) 30 day 90 day NIH stroke scale ( NIHSS ) baseline , 24 hr , 72 hr , 30 day 90 day . B ) MRI ( Diffusion weight image ) , 3-5 day 90 day C ) various plasma cellular endpoint measure blood collect baseline , 2 , 4 , 6 , 24 , 48 72 hr 30 day 90 day . The primary endpoint study detect difference percentage non diabetic subject mRS 0-2 90 day AIS treat endovascular therapy , IIT control arm .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Age 1885 year 2 . All patient attend emergency department ( ED ) Kaleida health within 24 hr symptom onset suggestive anterior circulation ischemic stroke . 3 . CT perfusion suggest Ischemic Core less 30 % Penumbra territory . 4 . No history diabetes 5 . First neurological event 6 . Clinical sign consistent diagnosis ischemic stroke , include impairment language , motor function , cognition and/or gaze , vision , neglect . Ischemic stroke defined event characterize sudden onset focal neurologic deficit presume due cerebral ischemia exclusion ICH baseline CT 7 . The signal stroke ( ) acute , ( b ) recent significant , acute worsen serial neurologic event , ( c ) relate diagnostic radiographic procedure interventional procedure 8 . Minimum NIHSS score &gt; 4 , except isolated aphasia isolate hemianopsia 9 . Angiographic evidence clot anterior intracranial extracranial circulation consistent neurologic deficit complete occlusion ( TICI grade 0 ) contrast penetration minimal perfusion ( TICI grade 1 ) . 10 . Signed informed consent participate give patient legal representative . 1 . Coma 2 . Neurologic sign rapidly improve time randomization treatment 4point improvement baseline NIHSS , increase absolute NIHSS &gt; 30 randomization treatment 3 . Major stroke symptom NIHSS &gt; 30 4 . Seizure onset stroke 5 . Stroke due neurointerventional procedure treatment cerebral aneurysm and/or cerebral arteriovenous malformation ( stroke due diagnostic cerebral angiography cardiac catheterization might treat ) 6 . Clinical presentation suggestive subarachnoid hemorrhage , even initial CT scan normal . 7 . Previous know ICH time , neoplasm , and/or subarachnoid hemorrhage . 8 . Patients know arteriovenous malformation aneurysm , without evidence associate hemorrhage . 9 . Presumed septic embolus 10 . Known hereditary acquire hemorrhagic diathesis , eg , aPTT prothrombin time great normal ; unsupported coagulation factor deficiency . 11 . Baseline laboratory value reveal platelet &lt; 30 000/ÂµL , hematocrit platelet cell volume &lt; 25 volume % , international normalize ratio &gt; 1.7 . ( Any patient receive heparin onset stroke symptom must aPTT 2 time upper limit normal randomization . Patients receive lowmolecularweight heparin might need exclude anticoagulant effect measure aPTT . ) 12 . Pregnancy , lactation , parturition within previous 30 day . 13 . Known serious sensitivity radiographic contrast agent . 14 . Other serious , advanced , terminal illness life expectancy &lt; 1 year . 15 . Current participation another research treatment protocol . 16 . Previous participation acute stroke study . 17 . Any condition angiography contraindicate . 18 . Uncompensated hypertension study entry hypertension require aggressive treatment reduce blood pressure nonhypertensive limit . Uncompensated hypertension define systolic blood pressure &gt; 180 mm Hg diastolic blood pressure 100 mm Hg 3 repeat measure least 10 minute apart . Aggressive treatment define need continuous , parenteral antihypertensive , nitroprusside drip , need administer &gt; 3 dos parenteral antihypertensive , labetalol , hydralazine , nicardepine . 19 . Dependency renal dialysis know serum creatinine &gt; 2.0mg/dl 20 . Serum glucose admission &lt; 80mg/dl 21 . All know diabetic patient 22 . Random Admission glucose &gt; 200mg/dl 23 . Highattenuation lesion CT consistent hemorrhage degree location . 24 . Evidence significant mass effect midline shift due large infarct 25 . Acute hypodense parenchymal lesion CT effacement cerebral sulcus one third MCA territory suspect stroke region 26 . Angiographic evidence ( ) Suspected carotid arterial dissection . ( b ) Arterial stenosis sole lesion highgrade stenosis allow safe passage catheter . ( b ) Any nonatherosclerotic arteriopathy ( eg , vasculitis ) 27 . Mentally incompetent ward state .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>